Virulence Characteristics and Antimicrobial Resistance Profiles of Shiga Toxin-Producing <i>Escherichia</i> <i>coli</i> Isolates from Humans in South Africa: 2006–2013

Shiga toxin-producing <i>Escherichia coli</i> (STEC) isolates (N = 38) that were incriminated in human disease from 2006 to 2013 in South Africa were characterized by serotype, virulence-associated genes, antimicrobial resistance and pulsed-field gel electrophoresis (PFGE). The isolates...

Full description

Bibliographic Details
Main Authors: Musafiri Karama, Beniamino T. Cenci-Goga, Mogaugedi Malahlela, Anthony M. Smith, Karen H. Keddy, Saeed El-Ashram, Lawan M. Kabiru, Alan Kalake
Format: Article
Language:English
Published: MDPI AG 2019-07-01
Series:Toxins
Subjects:
Online Access:https://www.mdpi.com/2072-6651/11/7/424
_version_ 1811186485001453568
author Musafiri Karama
Beniamino T. Cenci-Goga
Mogaugedi Malahlela
Anthony M. Smith
Karen H. Keddy
Saeed El-Ashram
Lawan M. Kabiru
Alan Kalake
author_facet Musafiri Karama
Beniamino T. Cenci-Goga
Mogaugedi Malahlela
Anthony M. Smith
Karen H. Keddy
Saeed El-Ashram
Lawan M. Kabiru
Alan Kalake
author_sort Musafiri Karama
collection DOAJ
description Shiga toxin-producing <i>Escherichia coli</i> (STEC) isolates (N = 38) that were incriminated in human disease from 2006 to 2013 in South Africa were characterized by serotype, virulence-associated genes, antimicrobial resistance and pulsed-field gel electrophoresis (PFGE). The isolates belonged to 11 O:H serotypes. STEC O26:H11 (24%) was the most frequent serotype associated with human disease, followed by O111:H8 (16%), O157:H7 (13%) and O117:H7 (13%). The majority of isolates were positive for key virulence-associated genes including <i>stx1</i> (84%), <i>eaeA</i> (61%), <i>ehxA</i> (68.4%) and <i>espP</i> (55%), but lacked <i>stx2</i> (29%), <i>katP</i> (42%), <i>etpD</i> (16%), <i>saa</i> (16%) and <i>subA</i> (3%). <i>stx2</i> positive isolates carried <i>stx2c</i> (26%) and/or <i>stx2d</i> (26%) subtypes. All pathogenicity island encoded virulence marker genes were detected in all (100%) isolates except <i>nleA</i> (47%), <i>nleC</i> (84%) and <i>nleD</i> (76%). Multidrug resistance was observed in 89% of isolates. PFGE revealed 34 profiles with eight distinct clusters that shared &#8805;80% intra-serotype similarity, regardless of the year of isolation. In conclusion, STEC isolates that were implicated in human disease between 2006 and 2013 in South Africa were mainly non-O157 strains which possessed virulence genes and markers commonly associated with STEC strains that have been incriminated in mild to severe human disease worldwide. Improved STEC monitoring and surveillance programs are needed in South Africa to control and prevent STEC disease in humans.
first_indexed 2024-04-11T13:46:11Z
format Article
id doaj.art-7358d0588f6c439c8dcc3efcccbcd3cd
institution Directory Open Access Journal
issn 2072-6651
language English
last_indexed 2024-04-11T13:46:11Z
publishDate 2019-07-01
publisher MDPI AG
record_format Article
series Toxins
spelling doaj.art-7358d0588f6c439c8dcc3efcccbcd3cd2022-12-22T04:21:03ZengMDPI AGToxins2072-66512019-07-0111742410.3390/toxins11070424toxins11070424Virulence Characteristics and Antimicrobial Resistance Profiles of Shiga Toxin-Producing <i>Escherichia</i> <i>coli</i> Isolates from Humans in South Africa: 2006–2013Musafiri Karama0Beniamino T. Cenci-Goga1Mogaugedi Malahlela2Anthony M. Smith3Karen H. Keddy4Saeed El-Ashram5Lawan M. Kabiru6Alan Kalake7Department of Paraclinical Sciences, Faculty of Veterinary Science, University of Pretoria, Onderstepoort 0110, South AfricaDepartment of Paraclinical Sciences, Faculty of Veterinary Science, University of Pretoria, Onderstepoort 0110, South AfricaDepartment of Paraclinical Sciences, Faculty of Veterinary Science, University of Pretoria, Onderstepoort 0110, South AfricaCentre for Enteric Diseases, National Institute for Communicable Diseases, Johannesburg 2131, South AfricaCentre for Enteric Diseases, National Institute for Communicable Diseases, Johannesburg 2131, South AfricaCollege of Life Science and Engineering, University Foshan, Foshan 528231, ChinaDepartment of Veterinary Public Health and Preventive Medicine, Ahmadu Bello University, Zaria 2222, NigeriaGauteng Department of Agriculture and Rural Development, Johannesburg 2001, South AfricaShiga toxin-producing <i>Escherichia coli</i> (STEC) isolates (N = 38) that were incriminated in human disease from 2006 to 2013 in South Africa were characterized by serotype, virulence-associated genes, antimicrobial resistance and pulsed-field gel electrophoresis (PFGE). The isolates belonged to 11 O:H serotypes. STEC O26:H11 (24%) was the most frequent serotype associated with human disease, followed by O111:H8 (16%), O157:H7 (13%) and O117:H7 (13%). The majority of isolates were positive for key virulence-associated genes including <i>stx1</i> (84%), <i>eaeA</i> (61%), <i>ehxA</i> (68.4%) and <i>espP</i> (55%), but lacked <i>stx2</i> (29%), <i>katP</i> (42%), <i>etpD</i> (16%), <i>saa</i> (16%) and <i>subA</i> (3%). <i>stx2</i> positive isolates carried <i>stx2c</i> (26%) and/or <i>stx2d</i> (26%) subtypes. All pathogenicity island encoded virulence marker genes were detected in all (100%) isolates except <i>nleA</i> (47%), <i>nleC</i> (84%) and <i>nleD</i> (76%). Multidrug resistance was observed in 89% of isolates. PFGE revealed 34 profiles with eight distinct clusters that shared &#8805;80% intra-serotype similarity, regardless of the year of isolation. In conclusion, STEC isolates that were implicated in human disease between 2006 and 2013 in South Africa were mainly non-O157 strains which possessed virulence genes and markers commonly associated with STEC strains that have been incriminated in mild to severe human disease worldwide. Improved STEC monitoring and surveillance programs are needed in South Africa to control and prevent STEC disease in humans.https://www.mdpi.com/2072-6651/11/7/424<title>Keywords</title>STEChumanvirulenceantimicrobial resistancePFGE
spellingShingle Musafiri Karama
Beniamino T. Cenci-Goga
Mogaugedi Malahlela
Anthony M. Smith
Karen H. Keddy
Saeed El-Ashram
Lawan M. Kabiru
Alan Kalake
Virulence Characteristics and Antimicrobial Resistance Profiles of Shiga Toxin-Producing <i>Escherichia</i> <i>coli</i> Isolates from Humans in South Africa: 2006–2013
Toxins
<title>Keywords</title>
STEC
human
virulence
antimicrobial resistance
PFGE
title Virulence Characteristics and Antimicrobial Resistance Profiles of Shiga Toxin-Producing <i>Escherichia</i> <i>coli</i> Isolates from Humans in South Africa: 2006–2013
title_full Virulence Characteristics and Antimicrobial Resistance Profiles of Shiga Toxin-Producing <i>Escherichia</i> <i>coli</i> Isolates from Humans in South Africa: 2006–2013
title_fullStr Virulence Characteristics and Antimicrobial Resistance Profiles of Shiga Toxin-Producing <i>Escherichia</i> <i>coli</i> Isolates from Humans in South Africa: 2006–2013
title_full_unstemmed Virulence Characteristics and Antimicrobial Resistance Profiles of Shiga Toxin-Producing <i>Escherichia</i> <i>coli</i> Isolates from Humans in South Africa: 2006–2013
title_short Virulence Characteristics and Antimicrobial Resistance Profiles of Shiga Toxin-Producing <i>Escherichia</i> <i>coli</i> Isolates from Humans in South Africa: 2006–2013
title_sort virulence characteristics and antimicrobial resistance profiles of shiga toxin producing i escherichia i i coli i isolates from humans in south africa 2006 2013
topic <title>Keywords</title>
STEC
human
virulence
antimicrobial resistance
PFGE
url https://www.mdpi.com/2072-6651/11/7/424
work_keys_str_mv AT musafirikarama virulencecharacteristicsandantimicrobialresistanceprofilesofshigatoxinproducingiescherichiaiicoliiisolatesfromhumansinsouthafrica20062013
AT beniaminotcencigoga virulencecharacteristicsandantimicrobialresistanceprofilesofshigatoxinproducingiescherichiaiicoliiisolatesfromhumansinsouthafrica20062013
AT mogaugedimalahlela virulencecharacteristicsandantimicrobialresistanceprofilesofshigatoxinproducingiescherichiaiicoliiisolatesfromhumansinsouthafrica20062013
AT anthonymsmith virulencecharacteristicsandantimicrobialresistanceprofilesofshigatoxinproducingiescherichiaiicoliiisolatesfromhumansinsouthafrica20062013
AT karenhkeddy virulencecharacteristicsandantimicrobialresistanceprofilesofshigatoxinproducingiescherichiaiicoliiisolatesfromhumansinsouthafrica20062013
AT saeedelashram virulencecharacteristicsandantimicrobialresistanceprofilesofshigatoxinproducingiescherichiaiicoliiisolatesfromhumansinsouthafrica20062013
AT lawanmkabiru virulencecharacteristicsandantimicrobialresistanceprofilesofshigatoxinproducingiescherichiaiicoliiisolatesfromhumansinsouthafrica20062013
AT alankalake virulencecharacteristicsandantimicrobialresistanceprofilesofshigatoxinproducingiescherichiaiicoliiisolatesfromhumansinsouthafrica20062013